Evidence map›Paper›PMID 33592542›Full record

ArticleDNA repair2021

USP13 regulates the replication stress response by deubiquitinating TopBP1.

Wootae Kim, Fei Zhao, Huanyao Gao, Sisi Qin, Jing Hou, Min Deng, Jake A Kloeber, Jinzhou Huang, Qin Zhou, Guijie Guo and 10 more

Open access · greenAbstract read
In one paragraph

Article in DNA repair, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Ubiquitin System-Driven Proteostasis in DNA Damage Response.International journal of molecular sciences · 2026
    Review
  3. Ubiquitin Proteasome System Components, RAD23A and USP13, Modulate TDP-43 Solubility and Neuronal Toxicity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Targeting replication stress in cancer therapy.Nature reviews. Drug discovery · 2023
    Review
  15. Article
  16. USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Article
  18. Role of USP13 in physiology and diseases.Frontiers in molecular biosciences · 2022
    Review
  19. USP13: Multiple Functions and Target Inhibition.Frontiers in cell and developmental biology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Wootae KimDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Fei ZhaoDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Huanyao GaoDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.
Sisi QinDepartment of Pathology, University of Chicago, Chicago, IL, 60637, USA.
Jing HouDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Min DengDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Jake A KloeberDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA; Mayo Clinic Medical Scientist Training Program, Mayo Clinic, Rochester, MN, 55905, USA.
Jinzhou HuangDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Qin ZhouDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Guijie GuoDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Ming GaoDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Xiangyu ZengDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Shouhai ZhuDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Xinyi TuDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Zheming WuDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Yong ZhangDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Ping YinDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Scott H KaufmannDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.
Kuntian LuoDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Zhenkun LouDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: lou.zhenkun@mayo.edu.
Mayo Clinic in Arizona · USMayo Clinic · USUniversity of Chicago · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
Regulation of homologous recombination and cancer cell response to chemoradiotherapyR01CA203561 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2016 to 2020
$1.8M
Deubiquitinases in regulation of BRCA1 pathwayR01CA203971 · NCI · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, LOU, ZHENKUN · 2016 to 2020
$1.8M
NCI NIH HHS P30 CA015083NCI NIH HHS R01 CA203561NCI NIH HHS R01 CA203971
6 · The paper itself

Abstract

The DNA replication stress-induced checkpoint activated through the TopBP1-ATR axis is important for maintaining genomic stability. However, the regulation of TopBP1 in DNA-damage responses remains unclear. In this study, we identify the deubiquitinating enzyme (DUB) USP13 as an important regulator of TopBP1. Mechanistically, USP13 binds to TopBP1 and stabilizes TopBP1 by deubiquitination. Depletion of USP13 impedes ATR activation and hypersensitizes cells to replication stress-inducing agents. Furthermore, high USP13 expression enhances the replication stress response, promotes cancer cell chemoresistance, and is correlated with poor prognosis of cancer patients. Overall, these findings suggest that USP13 is a novel deubiquitinating enzyme for TopBP1 and coordinates the replication stress response.

Indexed as

Cell Cycle CheckpointsDNA DamageDNA ReplicationUbiquitinationAtaxia Telangiectasia Mutated ProteinsCarrier ProteinsCell Cycle ProteinsCell Line, TumorDNADNA-Binding ProteinsHEK293 CellsHumansNuclear ProteinsUbiquitin-Specific ProteasesAtaxia Telangiectasia Mutated ProteinsATR protein, humanCarrier ProteinsCell Cycle ProteinsDNADNA-Binding ProteinsNuclear ProteinsTOPBP1 protein, humanUbiquitin-Specific ProteasesUSP13 protein, humanDNA damageReplicationTopBP1USP13

Identifiers

PMID33592542
PMCPMC7951086
OpenAlexW3128142271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.